Comments on: Home Office Cannabis potency study http://ukcia.org/wordpress/?p=49 news and comment about cannabis law reform from www.ukcia.org Tue, 07 Sep 2010 20:31:57 +0000 hourly 1 http://wordpress.org/?v=abc By: Mullray http://ukcia.org/wordpress/?p=49&cpage=1#comment-2579 Mullray Wed, 02 Jun 2010 10:14:02 +0000 http://ukcia.org/wordpress/?p=49#comment-2579 The UK seems a bit unique in a couple of ways. I.e. The term skunk being used for just about anything hydro. Elsewhere, we call hydro by it's genetic names (e.g. train wreck, sour diesel etc) even if they genetic name is incorrect - or we call it "hydro" or "hydie". Sensi is not a term I'm common with (re unseeded female flowers) after 30 years as a grower and smoker and mull dealer - at least not in the way you frame it. We elsewhere will call unseeded head sinse (pronounced since) or sensimilia. I think some may call it sensi but it's not by any means a standard. The UK seems a bit unique in a couple of ways. I.e. The term skunk being used for just about anything hydro. Elsewhere, we call hydro by it’s genetic names (e.g. train wreck, sour diesel etc) even if they genetic name is incorrect – or we call it “hydro” or “hydie”. Sensi is not a term I’m common with (re unseeded female flowers) after 30 years as a grower and smoker and mull dealer – at least not in the way you frame it. We elsewhere will call unseeded head sinse (pronounced since) or sensimilia. I think some may call it sensi but it’s not by any means a standard.

]]> By: Blair Anderson http://ukcia.org/wordpress/?p=49&cpage=1#comment-608 Blair Anderson Mon, 26 Jan 2009 01:29:18 +0000 http://ukcia.org/wordpress/?p=49#comment-608 (correction) The more something ‘valued’ is in demand the more moderate the use of the resource. (correction) The more something ‘valued’ is in demand the more moderate the use of the resource.

]]> By: Blair Anderson http://ukcia.org/wordpress/?p=49&cpage=1#comment-607 Blair Anderson Mon, 26 Jan 2009 01:26:19 +0000 http://ukcia.org/wordpress/?p=49#comment-607 The problem with cannabis 'potency' as a measure of harm (or goodness, if indeed that is the antonym) is that it fails to capture what is the governing factor in cannabis appeal. By postulating a measure, albeit flawed all we will arrive at is a need for 'more research, more funds, and time to assess the implications' whereas the real problem is with prohibitory practice itself. No credible epidemiological research can be accomplished while we are boxed into the 'illegal' because its against the law, predicated on a legacy of a moralism, racism, classism, ageism and sexism paradigm. The complex and variable nature of the human response is entirely subjective even with 'singular molecules'. We are not even sure how Aspro works. Trying to quantify (or qualify) cannabis in its many genetic variants is the logical equivalent of trying to 'formulate' a good wine (or beer). Why should cannabis be treated any different? What is needed is a viable market model containing the appropriate consumer protections (that prohibition clearly doesnt provide) and for the stigma associated with cannabis to be stripped away so that the mental health issues and attributes can be mediated. Stronger THC/CBD is not necessarily a harm producer. Nor too is increased prevalence or use. An informed consumer is the desired harm reduction agent. It imposes least cost management. Marketing reduces harm. The more something 'values' is in demand the more moderate the use of the resource, how many people get pissed on 'single malt'? More to the point, the marketing of this value creates a price break that actually protects against excess. How many people get pissed on "sherry" compared to Bruichladdich, Benrinnes 1991, or Glenfiddich. ( http://www.thewhiskyexchange.com/Producers.aspx ) Same for a good wine.. Use market value... at the prohibition on excess. The model for this has become law in New Zealand, where "Class D" extension to the 'misuse of drug act' adding restricted substances makes provision for psychoactive recreational soft drugs can be 'sold' under age controlled environment to consenting adults in a market environment not unlike that of alcohol, but with limits on advertising, requirements for packaging, labeling, point of sale, and content specifications insofar as they can be described. Now that's Progressive. (special thanks to frmr drug czar, assoc. health minister and leader of the Progressive Party, Jim Anderton). The problem with cannabis ‘potency’ as a measure of harm (or goodness, if indeed that is the antonym) is that it fails to capture what is the governing factor in cannabis appeal. By postulating a measure, albeit flawed all we will arrive at is a need for ‘more research, more funds, and time to assess the implications’ whereas the real problem is with prohibitory practice itself. No credible epidemiological research can be accomplished while we are boxed into the ‘illegal’ because its against the law, predicated on a legacy of a moralism, racism, classism, ageism and sexism paradigm.

The complex and variable nature of the human response is entirely subjective even with ‘singular molecules’. We are not even sure how Aspro works.

Trying to quantify (or qualify) cannabis in its many genetic variants is the logical equivalent of trying to ‘formulate’ a good wine (or beer).

Why should cannabis be treated any different?

What is needed is a viable market model containing the appropriate consumer protections (that prohibition clearly doesnt provide) and for the stigma associated with cannabis to be stripped away so that the mental health issues and attributes can be mediated.

Stronger THC/CBD is not necessarily a harm producer. Nor too is increased prevalence or use. An informed consumer is the desired harm reduction agent. It imposes least cost management.

Marketing reduces harm. The more something ‘values’ is in demand the more moderate the use of the resource, how many people get pissed on ‘single malt’? More to the point, the marketing of this value creates a price break that actually protects against excess. How many people get pissed on “sherry” compared to Bruichladdich, Benrinnes 1991, or Glenfiddich. ( http://www.thewhiskyexchange.com/Producers.aspx )

Same for a good wine..

Use market value… at the prohibition on excess.

The model for this has become law in New Zealand, where “Class D” extension to the ‘misuse of drug act’ adding restricted substances makes provision for psychoactive recreational soft drugs can be ‘sold’ under age controlled environment to consenting adults in a market environment not unlike that of alcohol, but with limits on advertising, requirements for packaging, labeling, point of sale, and content specifications insofar as they can be described.

Now that’s Progressive. (special thanks to frmr drug czar, assoc. health minister and leader of the Progressive Party, Jim Anderton).

]]>